国产一区二区三区视频精品-国产一区二区三区视频在线观看-国产一区二区三区四区五区-国产一区二区三区四区五区精品-国产一区二区三区无码免费-国产一区二区三区在线

國(guó)藥一致,Sinopharm Accord,  
國(guó)藥集團(tuán)一致藥業(yè)股份有限公司（簡(jiǎn)稱(chēng)國(guó)藥一致）是集醫(yī)藥研發(fā)、制藥工業(yè)、藥品分銷(xiāo)、醫(yī)藥物流為一體的綜合性醫(yī)藥上市公司（A股000028，B股200028），是中國(guó)醫(yī)藥集團(tuán)、國(guó)藥控股在中國(guó)南區(qū)的核心企業(yè)，承擔(dān)著國(guó)家、省、市政府藥品特儲(chǔ)任務(wù)。國(guó)藥一致?lián)碛泄I(yè)和分銷(xiāo)兩大業(yè)態(tài)，屬下企業(yè)共有32家，分布于廣東、廣西、江蘇等地區(qū)。截至目前，企業(yè)銷(xiāo)售規(guī)模超200億元，擁有員工4100多人。
　　國(guó)藥一致制藥工業(yè)集產(chǎn)品研發(fā)、原料與制劑生產(chǎn)、市場(chǎng)營(yíng)銷(xiāo)于一體，產(chǎn)品主要覆蓋抗感染、呼吸系統(tǒng)用藥、消化系統(tǒng)用藥、心腦血管用藥以及中成藥、保健品等領(lǐng)域。其全資企業(yè)深圳致君制藥有限公司、國(guó)藥控股深圳中藥有限公司，蘇州致君萬(wàn)慶藥業(yè)有限公司，參股企業(yè)深圳萬(wàn)樂(lè)藥業(yè)有限公司均為國(guó)家級(jí)高新技術(shù)企業(yè)，重點(diǎn)品種頭孢呋辛、頭孢克肟、頭孢西丁、頭孢米諾、頭孢哌坦等原料或制劑在細(xì)分市場(chǎng)處于領(lǐng)先地位，并擁有7個(gè)單品銷(xiāo)售超億元。其中，深圳致君制藥有限公司是國(guó)內(nèi)首家自主產(chǎn)品注冊(cè)通過(guò)歐盟GMP認(rèn)證的頭孢粉針制劑生產(chǎn)廠商，位列中國(guó)制藥工業(yè)企業(yè)50強(qiáng)。
　　國(guó)藥一致藥品分銷(xiāo)業(yè)務(wù)位居廣東、廣西榜首，名列中國(guó)醫(yī)藥商業(yè)20強(qiáng)，下屬企業(yè)29家，分布于深圳、廣州、東莞、佛山、湛江、梅州、肇慶、惠州、南寧、柳州、江門(mén)、桂林、玉林、百色等兩廣區(qū)域。分銷(xiāo)業(yè)務(wù)涵蓋醫(yī)院純銷(xiāo)、商業(yè)調(diào)撥、藥品快批及終端配送等，擁有完善的全國(guó)商業(yè)網(wǎng)絡(luò)和深度滲透的南區(qū)終端市場(chǎng)網(wǎng)絡(luò)，擁有華南地區(qū)自動(dòng)化程度最高、服務(wù)能力最強(qiáng)的專(zhuān)業(yè)醫(yī)藥物流中心，也是華南地區(qū)首家獲批第三方醫(yī)藥物流資質(zhì)的企業(yè)。目前，國(guó)藥一致分銷(xiāo)全力打造智慧型供應(yīng)鏈新的分銷(xiāo)商業(yè)模式，已在廣州、梅州等地開(kāi)設(shè)6家DTC專(zhuān)業(yè)藥房，并進(jìn)入B2B藥品電子商務(wù)領(lǐng)域。
　　未來(lái)，國(guó)藥一致將以內(nèi)涵增長(zhǎng)為主，由關(guān)注規(guī)模增長(zhǎng)轉(zhuǎn)變?yōu)橘|(zhì)量效益領(lǐng)先；充分內(nèi)部挖潛和資源整合；創(chuàng)新產(chǎn)品技術(shù)，創(chuàng)新商業(yè)模式，創(chuàng)新服務(wù)水平；積極發(fā)展新業(yè)務(wù)，堅(jiān)持科工貿(mào)協(xié)同發(fā)展，成為具有國(guó)際競(jìng)爭(zhēng)力的醫(yī)藥健康產(chǎn)品和服務(wù)提供商。
　　

愿景：以世界優(yōu)秀企業(yè)為標(biāo)桿，做中國(guó)醫(yī)藥企業(yè)的典范；
使命：生命與健康的守護(hù)者；
地址：深圳市福田區(qū)八卦四路15號(hào)一致藥業(yè)大廈

Brief introduction to China National Accord Medicines Corporation., Ltd
　 China National Accord Medicines Corporation., Ltd (short as Sinopharm Accord) is a comprehensive pharmaceutical publicly listed company (A Share: 000028, B Share: 200028) with four businesses—medicine distribution, pharmaceutical industry and pharmaceutical logistic. Our subordinate enterprises are distributed in Guangdong and Guangxi. Up to the end of 2007, the total asset of Sinopharm Accord amounts to 2,900,000,000 yuan and the annual sale exceeds 8,000,000,000 yuan.
　　The total employees in Sinopharm Accord reach 4,500. In 2004, the company transformed from Shenzhen state-owned enterprise into a member of China National Pharmaceutical Group Corporation. Sinopharm Accord promotes “Care for life, attend to health” as its enterprise concept and adheres to the Scientific development View as development by customer and market as orientation and organizational capability as its basis. With strategies of Strategic Drive and Integration Operation, Accordance Pharm brings along internal restructure, strategic adjustment, and alteration of marketing strategy. Deeper fine management has brought advance of three competitive edges “efficiency, variety and client” and improvement in three comprehensive abilities “operation, payoff and growth”.
　In the management control mode of integrated operation of the company, functions of headquarter is exercised by the four centers--operation management, finance management, human resource and administrative management. Management functions are exercised by the four business divisions—distribution division, pharmaceutical division, chain store division, logistics division.
　Sinopharm Holding Guangzhou Co., Ltd is the core enterprise of Distribution Division. With integrated operation, the division maximizes resource sharing such as verity, information, capital, logistic storage, and forms “Large Southern Region” platform of the medical & pharmaceutical business field in South China.
　Shenzhen Zhijun Pharmaceutical Co., Ltd.is the core enterprise of Pharmaceutical Division, the subsidiary of China National Pharmaceutical Group Corporation. With the advantage of the scientific research cooperation with Sichuan Industrial Institute of Antibiotics, the division has extended product lines, and developed relevant corollary equipment for the production of crude drug. With construction of an integrative industrial chain, the division enters into new field under appropriate situation, and quickens its deploitation of international mainstream marketplace. Accordance Pharm strives to become one of the top 20 of Chinese pharmaceutical industry in five years.
　Accordance Pharm Chain Store Co., Ltd is the large operation platform of Chain Store Division. Through connection with asset relationship, Accordance Pharm Chain Store will gradually shape itself into a pattern of unification between stock structure of chain type and management structure. The division aims to achieve a scale of 600 chain stores to reveal the brand influence of Accordance Drug Store and the power of terminal control in 2010.
　With support of the national integrated logistics distribution network of Sinopharm Holding and regional logistics warehouse with perfect corollary equipment, Logistics Division is devoted to meeting the requirement that the client network distribution be multi-terminal and deep coverage in all regions, strives to provide the customers solution of integrative logistic distribution, and develops to be the third logistic company in the pharmaceutical circulation domain.
　The prospective Accordance Pharm will continue to commit itself to the business restructuring and capital strategic operation and aims to become excellent public company in the China Medical and Pharmaceutical Industry and to become the first medical and pharmaceutical brand in South China.